Why is caution advised with mirabegron in patients with known QT prolongation?

Caution is advised because patients with known QT prolongation or taking QT-prolonging medicines were excluded from clinical studies, so mirabegron's effects in these patients are unknown, although therapeutic doses showed no clinically relevant QT prolongation.